Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
The Journal of Reproductive Medicine|March 1, 1991
Coronary heart disease risk markers in users of low-dose oral contraceptivesI F Godsland, D Crook, V WynnInternational Journal of Fertility|January 1, 1991
Oral contraceptives and metabolic risk markers for coronary heart diseaseD Crook, I F Godsland, V WynnClinical Science (London, England : 1979)|July 1, 1993
Venous blood arterialization and parameters from the minimal models of glucose disappearance and post-hepatic insulin deliveryI F Godsland, C Felton, V WynnAmerican Journal of Obstetrics and Gynecology|July 1, 1990
Low-dose oral contraceptives and carbohydrate metabolismI F Godsland, D Crook, V WynnAmerican Journal of Obstetrics and Gynecology|June 1, 1992
Clinical and metabolic considerations of long-term oral contraceptive useI F Godsland, D Crook, V WynnAmerican Journal of Obstetrics and Gynecology|June 1, 1988
Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestinsD Crook, I F Godsland, V WynnClinical Science (London, England : 1979)|December 1, 1986
Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol)I F Godsland, N M Shennan, V WynnDiabetologia|May 1, 1987
Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamicsN M Shennan, I F Godsland, V WynnEuropean Journal of Epidemiology|May 1, 1992
Insulin resistance--modelling studiesI F Godsland, C Walton, D Crook, et al.Contraception|September 1, 1995
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular diseaseI F Godsland, D Crook, M Devenport, et al.Pageof 15